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Abstract
Isolated cleft palate is among the most common human birth defects. The TCOF1 gene has been
suggested as a candidate gene for cleft palate based on animal models. This study tests for association
between markers in TCOF1 and isolated, nonsyndromic cleft palate using a case-parent trio design
considering parent-of-origin effects. Case-parent trios from three populations (comprising a total of
81 case-parent trios) were genotyped for single nucleotide polymorphisms (SNPs) in the TCOF1
gene. We used the transmission disequilibrium test and the transmission asymmetry test on individual
SNPs. When all trios were combined, the odds ratio for transmission of the minor allele, OR
(transmission), was significant for SNP rs15251 (OR = 2.88, P = 0.007), as well as rs2255796 and
rs2569062 (OR = 2.08, P = 0.03; OR = 2.43, P = 0.041; respectively) when parent of origin was not
considered. The transmission asymmetry test also revealed one SNP (rs15251) showing excess
maternal transmission significant at the P = 0.005 level (OR = 6.50). Parent-of-origin effects were
assessed using the parent-of-origin likelihood ratio test on both SNPs and haplotypes. While the
parent-of-origin likelihood ratio test was only marginally significant for this SNP (P = 0.136),
analysis of haplotypes of rs2255796 and rs15251 suggested excess maternal transmission. Therefore,
these data suggest TCOF1 may influence risk of cleft palate through a parent-of-origin effect.
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INTRODUCTION
Oral clefts are among the most common birth defects in humans and represent a significant
public health problem both in terms of the medical and economic burden for affected
individuals and their families. Nonsyndromic cleft palate (CP) is complex or multifactorial in
its etiology, in that both genes and environmental factors control risk [Wyszynski et al.,
1997; Cobourne, 2004]. Recently, several studies have reported that syndromic genes such as
IRF6 may be associated with nonsyndromic clefts [Stanier and Moore, 2004; Zucchero et al.,
2004].
The Treacher Collins-Franceschetti syndrome 1 (TCOF1 [OMIM 606847]) gene has been
shown to cause Treacher Collins syndrome (TCS, OMIM 154500), an autosomal dominant
craniofacial disorder [The Treacher Collins Syndrome Collaborative Group, 1996]. Treacher
Collins syndrome is characterized by hypoplasia of the facial bones, cleft palate, and middle
and external ear defects. TCOF1 is a unique spatiotemporal regulator of ribosome biogenesis,
a deficiency that disrupts neural crest cell formation and proliferation, causing the hypoplasia
characteristic of TCS craniofacial anomalies [Dixon et al., 2006]. However, to date no study
has focused on whether the TCOF1 gene is a risk factor for CP in humans.
It is important to consider parental effects when studying birth defects because maternal
genotype controls the in utero environment of the developing fetus, and separating maternal
genotypic effects from imprinting effects remains an important scientific question [Wilkins
and Haig, 2003; Weinberg and Umbach, 2005]. The functional activity of some genes or
chromosomal regions depends on whether they have been inherited maternally or paternally.
This epigenetic phenomenon is termed genomic imprinting [Infante-Rivard and Weinberg,
2005]. In this paper, we tested for association between markers in TCOF1 and risk of CP in
81 case-parent trios while specifically considering parent-of-origin effects.
MATERIALS AND METHODS
Sample Description
As part of an international study of oral clefts, we collected data on case-parent trios recruited
through treatment centers in Maryland (MD) (Johns Hopkins and University of Maryland), the
Chang Gung Memorial Hospital in Taiwan (TW), and KK Women’s and Children’s Hospital
in Singapore (SP). Research protocols were reviewed and approved by institutional review
boards (IRB) at each institution. A total of 81 case-parent trios from three populations (26
Taiwanese, 31 Singaporean, and 24 Maryland) were available. Among the 81 cases, 52 were
female and 29 were male, and all underwent a genetics evaluation (including assessing other
congenital anomalies or major developmental delays) and were classified as having an isolated,
nonsyndromic CP.
SNP Selection, DNA and Genotyping
Single nucleotide polymorphisms (SNP) were selected in a region surrounding TCOF1 on
chromosome 5q32–q33.1, with a goal of identifying one SNP per 5 kb of physical distance.
Variants with SNP scores above 0.6 (SNP score is an assessment of design quality of the
Illumina assay based on a proprietary algorithm), high validation levels in dbSNP (this included
validation levels where the submitter had validated the SNP on multiple platforms), and high
heterozygosity levels (particularly in multiple populations), were given higher priority during
the selection process. Of nine SNPs selected, only five were polymorphic in all populations.
Genomic DNA samples were prepared from peripheral blood by the protein precipitation
method described previously [Bellus et al., 1995]. DNA concentration was determined using
the PicoGreen® dsDNA Quantitation Kit (Molecular Probes, Inc., Eugene, OR) and all DNA
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samples were stored at −20°C. A 4 mg aliquot of each genomic DNA sample was dispensed
onto a bar-coded 96-well microtiter plate at a concentration of 100 ng/ml and genotyped for
SNP markers using the Illumina Golden-Gate™ chemistry with Sentrix® Array Matrices
[Oliphant et al., 2002] on a BeadLab 1000 system [Fan et al., 2003] at the SNP Center of the
Genetic Resources Core Facility (GRCF), a part of the McKusick-Nathans Institute of Genetic
Medicine, Johns Hopkins School of Medicine. Two duplicates and four CEPH controls were
included on each plate to evaluate genotyping consistency within and between plates and to
insure correct orientation. All genotypes were manually inspected and poorly performing SNPs
or samples were discarded prior to analysis.
Statistical Analysis
Trios from all three populations were combined for analysis of individual SNPs. The standard
transmission disequilibrium test (TDT) as described by Spielman et al. [1993] was used to test
for excess transmission of individual alleles. Parent-of-origin analyses were conducted in
several ways. Firstly, parent-of-origin effects were examined using Clayton’s extension of the
TDT incorporated into STATA 8.2 (Stata Corporation, 2005) which stratifies the standard TDT
into separate allelic tests for fathers and mothers [Cordell et al., 2004]. However, this approach
can give spurious results in the presence of either maternal effects or skewed distribution of
genotypes between parents [Weinberg et al., 1998]. Therefore, we performed the transmission
asymmetry test (TAT) suggested by Weinberg [1999] which is similar to the TDT but excludes
matings between two heterozygotes (where transmission can be ambiguous). Next, we used
the log-linear model proposed by Weinberg [1999] to test for parent-of-origin effect while
considering genotypes of both the mother and child. This method considers the three mating
types in which the mother and father carry different numbers of variant alleles, with further
stratification by the number of alleles inherited by the child. In this study, the minor allele
served as the variant or target allele. Following Weinberg, we call this latter method the parent-
of-origin likelihood ratio test (PO-LRT). This model accounts for maternally mediated in utero
effects (where maternal genotype affects the phenotype of the fetus) which could otherwise
confound assessment of parent-of-origin effects [Weinberg, 1999]. The LEM software was
used to carry out this PO-LRT [van Den Oord and Vermunt, 2000].
The FAMHAP package was used to estimate haplotype frequencies and to test for excess
transmission of multi-SNP haplotypes [Becker et al., 2006]. The FAMHAP package calculates
maximum likelihood estimates (MLEs) of haplotype frequencies (for up to 20 SNPs) from
nuclear families with varying numbers of children via the expectation-maximization algorithm
and is robust when handling missing SNPs [Becker and Knapp, 2004]. This program provides
a haplotype-based test for nuclear family data. This test statistic is based on Monte-Carlo
simulations, in which the set of transmitted and non-transmitted genotypes/haplotypes is
randomly permuted for each replicate [Zhao et al., 2000; Knapp and Becker, 2003]. In this
analysis, the chi-square statistic for marker combinations is replaced with the maximum chi-
square over single haplotypes (maximum TDT statistic). The program gives an empiric P-
value, corrected for the multiple haplotypes being considered. This haplotype analysis was also
carried out separately for maternal and paternal transmission.
RESULTS
Two of the nine SNPs were monomorphic, two had allele frequencies too low to be informative,
and one SNP had low call rates (only 68% complete trios), leaving only four SNPs with
reasonable heterozygosity (Table I). Only trios with complete data were used for the TDT and
TAT. When all markers were screened in the combined dataset using the TAT (i.e., where
heterozygous x heterozygous matings were dropped), the odds ratio for transmission of the
minor allele, OR(transmission), was statistically significant for SNP rs15251 (OR = 2.88, P =
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0.007), as well as rs2255796 and rs2569062 (OR = 2.08, P = 0.03; OR = 2.43, P = 0.041) when
parent of origin was ignored (Table II). Parent-of-origin effects were first investigated by
stratifying informative transmissions (T) and non-transmissions (NT) by parental source for
the four SNPs in the combined dataset (Table I). This analysis revealed SNP rs15251 showed
excess maternal transmission significant at the P = 0.005 level (OR = 6.50), however, the PO-
LRT was not significant at this SNP (P value = 0.136) perhaps due to the small sample sizes.
Among 81 CP cases, 40 were homozygous for the common allele, 30 were heterozygous, six
were homozygous for the minor allele, and four were missing for rs15251. Three mothers and
three fathers also had missing genotype data for rs15251, leaving a total of 72 complete trios
for this marker (rs15251).
Table III shows results of analyzing haplotypes of rs2255796 and rs15251 in each population.
Taiwan and Singapore parents had very similar haplotype frequencies, so all Asian trios were
combined. In the combined Asian data, haplotypes showed strong evidence of excess
transmission of the 1–1 haplotype to CP children (P = 0.009 for overall transmission). This
can be largely attributed to excess maternal transmission (P = 0.001) among Asian trios,
although the Maryland trios showed similar patterns. No haplotypes showed deviation from
the expected Mendelian transmission when transmitted from fathers.
DISCUSSION
Our study of cleft palate (CP) case-parent trios showed significant evidence of linkage and
disequilibrium for SNP rs15251 in the TCOF1 gene. SNP rs15251 is a nonsynonymous
mutation located in exon 23 of TCOF1 gene. In screening for parent-of-origin effects, we found
suggestive evidence of excess maternal transmission of this SNP. Analysis of haplotypes of
rs2255796 and rs15251 also showed significant deviation from expected for maternal
transmission, but not for paternal transmission.
TCOF1 gene was mapped in 1996 [The Treacher Collins Syndrome Collaborative Group,
1996] and subsequent studies have reported mutations throughout the 25 coding exons of this
gene. Furthermore, most reported pathogenic mutations are clustered in mutational hot spots
in five exons (10, 15, 16, 23, and 24) [Splendore et al., 2000]. Recently, in a study analyzing
22 sporadic Treacher Collins syndrome patients, Splendore et al. [2003] reported maternal
mutations at the exon 24 hot spot in TCOF1 gene. The present study is part of a larger candidate
gene study of oral clefts, and markers in TCOF1 were examined using family based association
test statistics in case-parent trios. Here we present results of analysis of SNPs including the
nonsynonymous SNP (rs15251) in exon 23.
Excess maternal transmission could reflect genomic imprinting or maternal genotype effects.
Maternal genotypic effects for nonsyndromic cleft lip with/without palate (CL/P) have also
been reported for several other candidate genes (MTHFR and CBS), but these have yet to be
confirmed [van Rooij et al., 2003; Rubini et al., 2005]. Our results for rs15251 in TCOF1 (both
analyzed alone and as a haplotype) showed evidence of excess maternal transmission, which
could reflect an imprinting effect or a maternal genotype effect.
The case-parent trio design offers the advantage of testing directly for maternal versus paternal
effects, and allows separating these from effects of the fetal genotype versus parental origin in
a robust manner [Sinsheimer et al., 2003; Cordell et al., 2004; Starr et al., 2005]. In the present
study, the PO-LRT for inequality between maternal and paternal transmission failed to
distinguish between these two forces, but this may be due to the limited number of informative
matings available here. Complete confirmation would require much larger samples of trios,
with resulting larger numbers of informative heterozygotes. Another advantage of this study
design is it minimizes issues of confounding that plague traditional case–control designs. This
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feature permitted pooling trios from diverse populations into a combined test explicitly
considering parent-of-origin effects. The present study suggests maternal transmission effects
for markers in TCOF1 and risk of nonsyndromic CP. Further work will be needed to confirm
this suggestion that maternal transmission of alleles in TCOF1 influence risk of CP and to
determine its ultimate impact on risk.
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